<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="115807">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT01667068</url>
  </required_header>
  <id_info>
    <org_study_id>12-4970-BO</org_study_id>
    <nct_id>NCT01667068</nct_id>
  </id_info>
  <brief_title>Cardiovascular Diseases in HIV-infected Patients HIV-HEART Study: 7.5 Years Follow-up</brief_title>
  <official_title>HIV-HEART STUDY: A Prospective, Epidemiologic and Multicentre Trial to Determine the Cardiovascular Risk in HIV-infected Patients</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University Hospital, Essen</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>HIV-HEART Study Investigative Group</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>German Heart Failure Network</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>German Federal Ministry of Education and Research</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Bristol-Myers Squibb GmbH &amp; Co. KG</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>ViiV Healthcare</agency>
      <agency_class>Industry</agency_class>
    </collaborator>
    <collaborator>
      <agency>Gilead Sciences GmbH</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Janssen-Cilag GmbH</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Abbott</agency>
      <agency_class>Industry</agency_class>
    </collaborator>
    <collaborator>
      <agency>Boehringer Ingelheim Pharma GmbH &amp; Co. KG</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>MSD Sharp &amp; Dohmen GmbH</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>University Hospital, Essen</source>
  <oversight_info>
    <authority>Germany: Federal Ministry of Education and Research</authority>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Since the introduction of antiretroviral therapy life expectancy of HIV-infected persons is
      rising. Different cohorts are observing an increased risk for cardiovascular diseases in
      this aging HIV-infected population. Traditional cardiovascular risk factors like smoking are
      more frequent in HIV-infected persons. For example chronic inflammation due to HIV-infection
      and metabolic disorders also caused by some antiretroviral substances as special
      non-traditional risk factors in HIV-infected persons can influence the development of
      cardiovascular diseases additionally. Therefore new research focus in special risk profile
      associated with HIV-infection or antiretroviral treatment and prevention for HIV-infected
      patients is developing.

      This present study is an ongoing prospective regional multicenter trial that was conducted
      to analyse the incidence, prevalence and clinical course of cardiovacular disorders in
      HIV-infected out-patients.

      Cardiac disorders witch are associated with HIV are pericarditis, pleural effusion,
      pulmonary hypertension, dilated cardiomyopathy, heart failure, myocarditis, bacterial
      endocarditis and heart valve disorders. In addition to previously stated disorders of the
      heart, the premature atherosclerosis of coronary arteries, a further even more important
      disease of the heart in this patient population, went into the focus of most HIV-researchers
      and physicians.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      A comprehensive detailed description of the study procedures had been previously published
      (European Journal of medical research 2007;12:243-248).
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date>April 2012</start_date>
  <completion_date type="Anticipated">October 2014</completion_date>
  <primary_completion_date type="Anticipated">May 2014</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Observational</study_type>
  <study_design>Observational Model: Cohort, Time Perspective: Prospective</study_design>
  <primary_outcome>
    <measure>Cardiovascular Diseases in HIV-infected Patients</measure>
    <time_frame>Baseline up to 7.5 follow-up to</time_frame>
    <safety_issue>No</safety_issue>
    <description>The detection of prevalence, aetiology, progression and severity of cardiovascular diseases - especially of coronary artery disease in HIV-infected patients.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Cardiovascular Disorders in HIV-infected Patients HIV-HEART</measure>
    <time_frame>Baseline up to 5 years follow-up</time_frame>
    <safety_issue>No</safety_issue>
    <description>Complementary the study also investigates the impact of classic cardiovascular risk factors like gender, age, blood fat and also new HIV-specific risk factors of coronary artery disease like viral-load, CD4-cell count and stage of the infection. The HIV-HEART study will focus the impact of medication including cardiovascular and antiretroviral medication. Further secondary objectives will be examined, including economic costs and the subjectively quality of life of subjects with and without cardiovascular diseases in this patient population.</description>
  </secondary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Anticipated">1450</enrollment>
  <condition>Coronary Heart Disease</condition>
  <condition>Heart Failure</condition>
  <condition>HIV</condition>
  <condition>AIDS</condition>
  <condition>Metabolic Syndrome</condition>
  <arm_group>
    <arm_group_label>Regional Ruhrgebiets Cohort</arm_group_label>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Comprehensive non invasive cardiovascular examination</intervention_name>
    <description>Anamnesis with the participian
File recherche,Physical examination
Documentation of the carciovascular and antiretroviral medical therapy
Electrocardiogram
Transthoracic echocardiography
Exercise electrocardiogram
Measuring of the arterial media thickness
Exercise Montreal Cognitive Assesment test
Exercise the Grooved Pegboard test
Blood collection
Questionnaire to quality of life and health economics</description>
    <arm_group_label>Regional Ruhrgebiets Cohort</arm_group_label>
  </intervention>
  <biospec_descr>
    <textblock>
      Stored blood samples
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        Participiants were included in several cities of the Ruhrarea. Locations were Essen,
        Bochum, Dortmund and Duisburg The study population included outpatients who were at least
        18 years of age, had a known HIV-infection and exhibited a stable disease status within 4
        weeks before inclusion of the trial. Written informed consent was obtained from all
        participants.
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Age &gt; 18 years

          -  Known HIV-infection

          -  Written informed consent

        Exclusion Criteria:

          -  Acute cardiovascular disease

          -  Unstable hemodynamic status in the three weeks before inclusion

          -  Pregnancy
      </textblock>
    </criteria>
    <gender>Both</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Stefan Esser, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University Hospital, Essen</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Till Neumann Neumann, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University Hospital, Essen</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Stefan Esser, MD</last_name>
    <phone>++49 201 723 3878</phone>
    <email>stefan.esser@uk-essen.de</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Till Neumann, MD</last_name>
    <phone>++49 201 723 4806</phone>
    <email>till.neumann@uk-essen.de</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>University Hospital of Bochum, Department of Dermatology</name>
      <address>
        <city>Bochum</city>
        <zip>44791</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Norbert Brockmeyer, MD</last_name>
      <phone>++49 234 509 3471</phone>
      <email>n.brockmeyer@derma.de</email>
    </contact>
    <contact_backup>
      <last_name>Anja Potthoff, MD</last_name>
      <phone>++49 0234/509-1</phone>
      <email>a.potthoff@klinikum-bochum.de</email>
    </contact_backup>
  </location>
  <location>
    <facility>
      <name>HIV Outpatient Department</name>
      <address>
        <city>Dortmund</city>
        <zip>44137</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Martin Hower, MD</last_name>
      <phone>++49 95320700</phone>
      <email>ID.ambulanz@klinikumdo.de</email>
    </contact>
    <contact_backup>
      <last_name>Claudia Bachmann, Study nurse</last_name>
      <phone>++49 95320700</phone>
      <email>ID.ambulanz@klinikumdo.de</email>
    </contact_backup>
  </location>
  <location>
    <facility>
      <name>Health Center</name>
      <address>
        <city>Duisburg</city>
        <zip>47249</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Ingulf Becker-Boost, MD</last_name>
      <phone>++49 20348800110</phone>
      <email>onkologie.beckerboost@gzs-du.de</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>University Hospital, Department of Dermatology and Venerology</name>
      <address>
        <city>Essen</city>
        <zip>45147</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Stefan Esser, MD</last_name>
      <phone>++49 201 723 3878</phone>
      <email>stefan.esser@uk-essen.de</email>
    </contact>
    <contact_backup>
      <last_name>Anna Warnke, MD</last_name>
      <phone>++49 201 723 4741</phone>
      <email>anna.warnke@uk-essen.de</email>
    </contact_backup>
  </location>
  <location>
    <facility>
      <name>University Hospital, West German Heart Center Essen</name>
      <address>
        <city>Essen</city>
        <zip>45147</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Till Neumann, MD</last_name>
      <phone>++49 201 723 4806</phone>
      <email>till.neumann@k-essen.de</email>
    </contact>
    <contact_backup>
      <last_name>Christina Schulze, Study Nurse</last_name>
      <phone>++49 201 723 4878</phone>
      <email>Christina.Schulze@uk-essen.de</email>
    </contact_backup>
  </location>
  <location>
    <facility>
      <name>Clinical Coordinating Center Leipzig</name>
      <address>
        <city>Leipzig</city>
        <zip>04107</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Active, not recruiting</status>
  </location>
  <location_countries>
    <country>Germany</country>
  </location_countries>
  <link>
    <url>http://www.hiv-heart.de</url>
    <description>Internet presentation of current Study</description>
  </link>
  <results_reference>
    <citation>Neumann T. [HIV, AIDS and the cardiovascular risk] Internist (Berl). 2008 Apr;49(4):429-30, 432-5. Review. German.</citation>
    <PMID>18305915</PMID>
  </results_reference>
  <results_reference>
    <citation>Reinsch N, Buhr C, Krings P, Kaelsch H, Kahlert P, Konorza T, Neumann T, Erbel R; Competence Network of Heart Failure. Effect of gender and highly active antiretroviral therapy on HIV-related pulmonary arterial hypertension: results of the HIV-HEART Study. HIV Med. 2008 Aug;9(7):550-6. Epub 2008 Jun 28.</citation>
    <PMID>18557952</PMID>
  </results_reference>
  <results_reference>
    <citation>Reinsch N, Buhr C, Krings P, Kaelsch H, Neuhaus K, Wieneke H, Erbel R, Neumann T; German Heart Failure Network. Prevalence and risk factors of prolonged QTc interval in HIV-infected patients: results of the HIV-HEART study. HIV Clin Trials. 2009 Jul-Aug;10(4):261-8.</citation>
    <PMID>19723613</PMID>
  </results_reference>
  <results_reference>
    <citation>Neumann T, Reinsch N, Neuhaus K, Brockmeyer N, Potthoff A, Esser S, Hower M, Neumann A, Mostardt S, Gelbrich G, Erbel R; für die HIV-HEART-Studie sowie die Kompetenznetze Herzinsuffizienz und HIV/AIDS. [BNP in HIV-infected patients]. Herz. 2009 Dec;34(8):634-40. doi: 10.1007/s00059-009-3313-7. German.</citation>
    <PMID>20024643</PMID>
  </results_reference>
  <results_reference>
    <citation>Neumann T, Esser S, Potthoff A, Pankuweit S, Neumann A, Breuckmann F, Neuhaus K, Kondratieva J, Buck T, Müller-Tasch T, Wachter R, Prettin C, Gelbrich G, Herzog W, Pieske B, Rauchhaus M, Löffler M, Maisch B, Mügge A, Wasem J, Gerken G, Brockmeyer NH, Erbel R; HIV-HEART Study Investigative Group. Prevalence and natural history of heart failure in outpatient HIV-infected subjects: rationale and design of the HIV-HEART study. Eur J Med Res. 2007 Jun 27;12(6):243-8.</citation>
    <PMID>17666313</PMID>
  </results_reference>
  <results_reference>
    <citation>Breuckmann F, Neumann T, Kondratieva J, Wieneke H, Ross B, Nassenstein K, Barkhausen J, Kreuter A, Brockmeyer N, Erbel R. Dilated cardiomyopathy in two adult human immunodeficiency positive (HIV+) patients possibly related to highly active antiretroviral therapy (HAART). Eur J Med Res. 2005 Sep 12;10(9):395-9.</citation>
    <PMID>16183552</PMID>
  </results_reference>
  <results_reference>
    <citation>Reinsch N, Kahlert P, Esser S, Sundermeyer A, Neuhaus K, Brockmeyer N, Potthoff A, Erbel R, Buck T, Neumann T. Echocardiographic findings and abnormalities in HIV-infected patients: results from a large, prospective, multicenter HIV-heart study. Am J Cardiovasc Dis. 2011;1(2):176-84. Epub 2011 Jul 30.</citation>
    <PMID>22254197</PMID>
  </results_reference>
  <results_reference>
    <citation>Lind A, Reinsch N, Neuhaus K, Esser S, Brockmeyer NH, Potthoff A, Pankuweit S, Erbel R, Maisch B, Neumann T. Pericardial effusion of HIV-infected patients ? Results of a prospective multicenter cohort study in the era of antiretroviral therapy. Eur J Med Res. 2011 Nov 10;16(11):480-3.</citation>
    <PMID>22027640</PMID>
  </results_reference>
  <results_reference>
    <citation>Gelbrich B, Neumann T, Esser S, Potthoff A, Reinsch N, Hower M, Dannhauer KH, Loeffler M, Brockmeyer NH, Erbel R, Gelbrich G; HIV-HEART Study Investigative Group, Competence Networks Heart Failure and HIV/AIDS. Oral health and the heart - does HIV infection open a pathophysiological gateway? Int J Cardiol. 2011 Sep 1;151(2):254-7. Epub 2011 Jul 18.</citation>
    <PMID>21764468</PMID>
  </results_reference>
  <results_reference>
    <citation>Reinsch N, Neuhaus K, Esser S, Potthoff A, Hower M, Mostardt S, Neumann A, Brockmeyer NH, Gelbrich G, Erbel R, Neumann T; German Competence Network Heart Failure; German Competence Network for HIV/AIDS. Are HIV patients undertreated? Cardiovascular risk factors in HIV: results of the HIV-HEART study. Eur J Prev Cardiol. 2012 Apr;19(2):267-74. doi: 10.1177/1741826711398431. Epub 2011 Feb 28.</citation>
    <PMID>21450595</PMID>
  </results_reference>
  <results_reference>
    <citation>Reinsch N, Neuhaus K, Esser S, Potthoff A, Hower M, Brockmeyer NH, Erbel R, Neumann T; German Competence Network for Heart Failure; German Competence Network for HIV AIDS. Prevalence of cardiac diastolic dysfunction in HIV-infected patients: results of the HIV-HEART study. HIV Clin Trials. 2010 May-Jun;11(3):156-62.</citation>
    <PMID>20739268</PMID>
  </results_reference>
  <results_reference>
    <citation>Potthoff A, Brockmeyer NH, Gelbrich G, Neuhaus K, Esser S, Reinsch N, Hower M, Mostardt S, Neumann A, Neumann T; Competence Center Cardiac Insufficiency and the Competence Network HIV/AIDS. Lipodystrophy - a sign for metabolic syndrome in patients of the HIV-HEART study. J Dtsch Dermatol Ges. 2010 Feb;8(2):92-8. doi: 10.1111/j.1610-0387.2009.07330.x. Epub 2009 Dec 14. English, German.</citation>
    <PMID>20002869</PMID>
  </results_reference>
  <verification_date>April 2012</verification_date>
  <lastchanged_date>August 16, 2012</lastchanged_date>
  <firstreceived_date>August 16, 2012</firstreceived_date>
  <keyword>Cardiac Diseases</keyword>
  <keyword>HIV-Infection</keyword>
  <keyword>AIDS</keyword>
  <keyword>Antiretroviral Therapy</keyword>
  <keyword>Cardiovascular Medication</keyword>
  <keyword>Risk Factors</keyword>
  <keyword>coronary heart disease</keyword>
  <keyword>heart failure</keyword>
  <keyword>metabolic syndrome</keyword>
  <is_fda_regulated>No</is_fda_regulated>
  <has_expanded_access>No</has_expanded_access>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Acquired Immunodeficiency Syndrome</mesh_term>
    <mesh_term>Cardiovascular Diseases</mesh_term>
    <mesh_term>Coronary Artery Disease</mesh_term>
    <mesh_term>Myocardial Ischemia</mesh_term>
    <mesh_term>Coronary Disease</mesh_term>
    <mesh_term>Heart Diseases</mesh_term>
    <mesh_term>Heart Failure</mesh_term>
    <mesh_term>Metabolic Syndrome X</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Cardiovascular Agents</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
